To further dissect the mechanistic basis for Y33 IC-induced CD8+ T cell potentiation in mouse tumor models, we evaluated the potential of this IC to stimulate expansion and effector molecule expression in antigen-primed CD8+ T cells. Here, CD8A is linked to neoplasm.